The Fleming Genomics Facility was a member of the Hellenic Network for Precision Medicine in Oncology since 2018 (EDIAO) and, since 2023, is a member of the Hellenic Network of Molecular Oncology (EDIMO). It provides gene panel sequencing on solid tumors for patients referred from a multitude of Athens area hospitals. The Fleming Genomics Facility has been accredited under the terms of ELOT EN ISO 15189:2012 (Cert. No. 1270).
